568 related articles for article (PubMed ID: 8786875)
1. Pathologic considerations of uterine smooth muscle tumors.
Prayson RA; Hart WR
Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
[TBL] [Abstract][Full Text] [Related]
2. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
3. Pathology, cytogenetics and molecular biology of uterine leiomyomas and other smooth muscle lesions.
Quade BJ
Curr Opin Obstet Gynecol; 1995 Feb; 7(1):35-42. PubMed ID: 7742513
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
Shanes ED; Friedman LA; Mills AM
Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
[TBL] [Abstract][Full Text] [Related]
6. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
Bell SW; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
[TBL] [Abstract][Full Text] [Related]
7. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases.
Lee TK; Miyamoto H; Osunkoya AO; Guo CC; Weiss SW; Epstein JI
Am J Surg Pathol; 2010 Apr; 34(4):502-9. PubMed ID: 20154594
[TBL] [Abstract][Full Text] [Related]
8. Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.
Patil DT; Laskin WB; Fetsch JF; Miettinen M
Am J Surg Pathol; 2011 Mar; 35(3):315-24. PubMed ID: 21297441
[TBL] [Abstract][Full Text] [Related]
9. Unusual morphological features of uterine leiomyomas treated with progestogens.
Boyd C; McCluggage WG
J Clin Pathol; 2011 Jun; 64(6):485-9. PubMed ID: 21398323
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
Fadare O; Liang SX
Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
[TBL] [Abstract][Full Text] [Related]
11. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
13. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
Shi YF; Xie X; Zhao CL
Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
[TBL] [Abstract][Full Text] [Related]
14. Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
Burns B; Curry RH; Bell ME
Am J Obstet Gynecol; 1979 Sep; 135(1):109-14. PubMed ID: 474641
[TBL] [Abstract][Full Text] [Related]
15. Unusual types of smooth muscle tumors of uterine corpus: case reports and literature review.
Makharoblidze E; Goishvili N; Mchedlishvili M; Khakhutaishvili I; Jangavadze M
Georgian Med News; 2013 Mar; (216):7-11. PubMed ID: 23567300
[TBL] [Abstract][Full Text] [Related]
16. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.
Tanaka YO; Nishida M; Tsunoda H; Okamoto Y; Yoshikawa H
J Magn Reson Imaging; 2004 Dec; 20(6):998-1007. PubMed ID: 15558559
[TBL] [Abstract][Full Text] [Related]
19. Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.
Ip PP; Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):691-704. PubMed ID: 21865091
[TBL] [Abstract][Full Text] [Related]
20. Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients.
Prayson RA; Goldblum JR; Hart WR
Am J Surg Pathol; 1997 Apr; 21(4):383-91. PubMed ID: 9130984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]